US2005025815A1PendingUtilityA1

Devices for improved wound management

55
Assignee: OLIGOS ETC INCPriority: Dec 30, 1998Filed: Aug 21, 2003Published: Feb 3, 2005
Est. expiryDec 30, 2018(expired)· nominal 20-yr term from priority
A01N 57/16A61L 27/60A61L 2300/258A61P 31/04A61L 15/46A61L 24/106A61L 17/005A61K 8/606A61B 2017/00893A61B 17/06166A61L 17/105A61L 27/54A61P 31/02A61K 31/70A61L 17/04A61Q 19/00A61L 2300/404A61L 24/0015
55
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides devices and compositions for the management of infection of topical lesions, each of the devices and compositions containing protonated/acidified nucleic acids either on its surface, or integrated into the device. These modified nucleic acids are effective as bactericidal and/or bacteriostatic agents without regard to the class of bacteria, so are especially useful when diagnosis is difficult or when multiple infectious organisms are present. The antibiotic activity of nucleic acids of the invention is not dependent on either the specific sequence of the nucleic acid or the length of the nucleic acid molecule. The nucleic acids used in the invention are protonated/acidified to give a pH when dissolved in water of less than pH 7 to about 1, more preferably less than pH 4.5 to about 1, and even more preferably less than pH 2 to about 1.

Claims

exact text as granted — not AI-modified
1 . A wound dressing comprising: 
 a solid substrate; and    a formulation of protonated/acidified nucleic acid.    
     
     
         2 - 31 . (canceled)

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.